Shinno Y - Search Results

1

Performance of Japanese patients in registrational studies.

Goto Y, Arakawa S, Shirasawa M, Higashiyama R, Baba K, Masuda K, Shinno Y, Matsumoto Y, Okuma Y, Yoshida T, Horinouchi H, Yamamoto N, Ohe Y. Goto Y, et al. Among authors: shinno y. Jpn J Clin Oncol. 2022 Jan 3;52(1):53-64. doi: 10.1093/jjco/hyab171. Jpn J Clin Oncol. 2022. PMID: 34978326

2

Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.

Shinno Y, Kage H, Chino H, Inaba A, Arakawa S, Noguchi S, Amano Y, Yamauchi Y, Tanaka G, Nagase T. Shinno Y, et al. Respirology. 2018 Jan;23(1):55-59. doi: 10.1111/resp.13192. Epub 2017 Oct 4. Respirology. 2018. PMID: 28980363

3

Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations.

Shinno Y, Goto Y, Watanabe S, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y. Shinno Y, et al. ESMO Open. 2018 Nov 28;3(7):e000399. doi: 10.1136/esmoopen-2018-000399. eCollection 2018. ESMO Open. 2018. PMID: 30559979 Free PMC article.

4

Mixed response to osimertinib and the beneficial effects of additional local therapy.

Shinno Y, Goto Y, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y. Shinno Y, et al. Thorac Cancer. 2019 Apr;10(4):738-743. doi: 10.1111/1759-7714.12991. Epub 2019 Feb 8. Thorac Cancer. 2019. PMID: 30735003 Free PMC article.

5

Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer.

Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Motoi N, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: shinno y. Thorac Cancer. 2019 Apr;10(4):815-822. doi: 10.1111/1759-7714.13004. Epub 2019 Feb 14. Thorac Cancer. 2019. PMID: 30762312 Free PMC article.

6

Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis.

Masuda K, Fujiwara Y, Shinno Y, Mizuno T, Sato J, Morita R, Matsumoto Y, Murakami S, Goto Y, Kanda S, Horinouchi H, Yamamoto N, Ohe Y. Masuda K, et al. Among authors: shinno y. J Thorac Dis. 2019 Jul;11(7):2965-2972. doi: 10.21037/jtd.2019.07.44. J Thorac Dis. 2019. PMID: 31463126 Free PMC article.

7

Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.

Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Yoshida T, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: shinno y. Cancer Immunol Immunother. 2020 Jul;69(7):1229-1236. doi: 10.1007/s00262-020-02539-2. Epub 2020 Mar 10. Cancer Immunol Immunother. 2020. PMID: 32152703 Free PMC article.

8

Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer.

Ida H, Goto Y, Sato J, Kanda S, Shinno Y, Morita R, Murakami S, Matsumoto Y, Yoshida T, Horinouchi H, Fujiwara Y, Yamamoto N, Fukuda T, Ohashi K, Ohe Y. Ida H, et al. Among authors: shinno y. Med Oncol. 2020 Mar 16;37(4):30. doi: 10.1007/s12032-020-01357-x. Med Oncol. 2020. PMID: 32180046

9

Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression.

Masuda K, Horinouchi H, Tanaka M, Higashiyama R, Shinno Y, Sato J, Matsumoto Y, Okuma Y, Yoshida T, Goto Y, Yamamoto N, Ohe Y. Masuda K, et al. Among authors: shinno y. J Cancer Res Clin Oncol. 2021 Jan;147(1):245-251. doi: 10.1007/s00432-020-03329-0. Epub 2020 Jul 23. J Cancer Res Clin Oncol. 2021. PMID: 32705363 Free PMC article. Clinical Trial.

10

Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer.

Shirasawa M, Yoshida T, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Watanabe SI, Ohe Y, Motoi N. Shirasawa M, et al. Among authors: shinno y. Eur J Cancer. 2020 Nov;140:28-36. doi: 10.1016/j.ejca.2020.08.028. Epub 2020 Oct 8. Eur J Cancer. 2020. PMID: 33039811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters